BioAdvance News

CEO of Group K Diagnostics Nominated to the Philadelphia Startup Leaders Board

By WebmasterDecember 7, 2018November 1st, 2024No Comments

CEO of Group K Diagnostics Nominated to the Philadelphia Startup Leaders Board

Previous PostRelmada Therapeutics Presents Clinical Data on Increased BDNF Plasma Levels in Subjects Treated with REL-1017
Next PostPillo Health Launches Innovative Home Health Assistant to Dispense Medication, Track Adherence, Deliver Care Plans